Quality of life amongst adolescents and young adults with cystic fibrosis: correlations with clinical outcomes

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2018
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CLINICS, v.73, article ID UNSP e427, 6p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: The current study sought to evaluate the quality of life of young patients with cystic fibrosis and correlate these results with the clinical parameters indicative of disease severity. METHODS: This cross-sectional study applied the validated Portuguese version of a cystic fibrosis specific quality of life questionnaire to clinically stable patients aged 14 to 21 years old. The correlations between the questionnaire domain scores and forced expiratory volume in one second (FEV1) values, the Shwachman-Kulczycki score, and body mass index were assessed, and correlations were considered as significant when p<0.05. RESULTS: A total of 31 patients (11 females; 16.4 +/- 2.3 years old) were evaluated, and the median scores on the questionnaire domains ranged from 66.7 to 100. A significant correlation was found between body mass index and the weight (r=0.43, p=0.016) and the eating questionnaire domains (r=0.44, p=0.013); between FEV1 and the physical (r=0.53, p=0.002) and treatment burden (r=0.41, p=0.023) domains; and between the Shwachman-Kulczycki score and the physical (r=0.39, p=0.03), health (r=0.41, p=0.023), and role (r=0.37, p=0.041) domains. A significant difference was found amongst patients with FEV1 values above or below 60% of the predicted value with regard to the role and health domains. No differences in the scores were found according to gender. CONCLUSIONS: The current cystic fibrosis specific quality of life questionnaire scores exhibited wide variability across all domains; however, they indicated a relatively satisfactory quality of life amongst the patients studied. Certain domains exhibited significant correlations with clinical parameters; thus, this instrument has consistent associations with clinical outcomes.
Palavras-chave
Cystic Fibrosis, Quality of Life, Questionnaires, Adolescence
Referências
  1. Abbott J, 2011, J CYST FIBROS, V10, pS82, DOI 10.1016/S1569-1993(11)60013-1
  2. Abbott J, 2013, THORAX, V68, P149, DOI 10.1136/thoraxjnl-2012-202552
  3. Arrington-Sanders R, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-5
  4. Cohen MA, 2011, J BRAS PNEUMOL, V37, P184, DOI 10.1590/S1806-37132011000200008
  5. Cystic Fibrosis Foundation Patient Registry, 2016, ANN DAT REP
  6. Farrell PM, 2008, J PEDIATR, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005
  7. Forte GC, 2015, RESP CARE, V60, P1459, DOI 10.4187/respcare.03665
  8. Gee L, 2003, J Cyst Fibros, V2, P206, DOI 10.1016/S1569-1993(03)00093-6
  9. Gee Louise, 2005, J Cyst Fibros, V4, P59, DOI 10.1016/j.jcf.2004.12.005
  10. Groeneveld IF, 2012, QUAL LIFE RES, V21, P1837, DOI 10.1007/s11136-011-0100-8
  11. Henry B, 2003, QUAL LIFE RES, V12, P63, DOI 10.1023/A:1022037320039
  12. Klijn Peter H, 2004, J Cyst Fibros, V3, P29
  13. KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725
  14. Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8
  15. Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
  16. O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5
  17. Olveira G, 2010, ARCH BRONCONEUMOL, V46, P165, DOI 10.1016/j.arbres.2010.01.006
  18. Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205
  19. Polgar G, 1971, PULMONARY FUNCTION T
  20. Quittner AL, 2000, J PEDIATR PSYCHOL, V25, P403, DOI 10.1093/jpepsy/25.6.403
  21. Quittner AL, 2005, CHEST, V128, P2347, DOI 10.1378/chest.128.4.2347
  22. Quittner AL, 2003, CYSTIC FIBROSIS QUES
  23. Quittner AL, 2008, PAEDIATR RESPIR REV, V9, P220, DOI 10.1016/j.prrv.2008.05.003
  24. Quittner AL, 2012, QUAL LIFE RES, V21, P1267, DOI [10.1007/s11136-011-0091-5, 10.1007/s11136-011-0036-z]
  25. Rozov Tatiana, 2006, J. Pediatr. (Rio J.), V82, P151, DOI 10.1590/S0021-75572006000200013
  26. Rozov T, 2010, PEDIATR PULM, V45, P874, DOI 10.1002/ppul.21267
  27. Sawicki GS, 2011, PEDIATR PULM, V46, P36, DOI 10.1002/ppul.21325
  28. Sawyer SM, 2007, LANCET, V369, P1481, DOI 10.1016/S0140-6736(07)60370-5
  29. Shoff SM, 2013, J CYST FIBROS, V12, P746, DOI 10.1016/j.jcf.2013.01.006
  30. SHWACHMAN H, 1958, AMA J DIS CHILD, V96, P6, DOI 10.1001/archpedi.1958.02060060008002
  31. Tibosch MM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-86
  32. Tluczek A, 2011, CHEST, V140, P170, DOI 10.1378/chest.10-1504
  33. Ziaian T, 2006, J PAEDIATR CHILD H, V42, P596, DOI 10.1111/j.1440-1754.2006.00943.x